alan venook, md, on the keynote-177 study investigating msi high/mismatch repair deficient mcrc
Published 4 years ago • 67 plays • Length 3:22
Download video MP4
Download video MP3
Similar videos
-
3:08
alan venook, md, discusses uniqueness of msi-high/mismatch repair deficient crc patients
-
2:16
alan venook, md, describes the potential practice changing results of the keynote-177 study
-
2:12
alan venook, md, considers how i-o is evolving towards the first line treatment of colorectal cancer
-
1:39
alan venook, md, discusses next generation sequencing and mcrc treatment
-
2:16
alan venook, md, on potential new standard in care post approval of atezolizumab bevacizumab
-
8:10
william trattler, md: the oculus pentacam® - case presentations, screening for refractive surgery
-
15:26
thomas kohnen, md – iol master vs. pentacam® axl
-
1:08:22
diagnosing alzheimer’s disease in the biomarker era: promises and pitfalls | professor ron petersen
-
1:47
alan venook, md discusses development of immunotherapies for non msi-high crc patients
-
1:44
alan venook, md, considers how immunotherapy is being integrated into crc treatment algorithms
-
1:38
alan venook, md explains the outcome of phase 3 calgb/swog 80405 study
-
1:18
alan venook, md, on the latest in identifying valid biomarkers in the treatment of hcc
-
5:35
howard hochster, md, discusses the outcomes of the keynote-177 study in metastatic crc
-
1:30
alan venook, md, discusses vemurafenib and the nccn guidelines for mcrc patients
-
1:05
alan p. venook, md, on integrating immunotherapy into treatment regimens for gastric cancer patients
-
2:59
alan venook, md, provides opinions of the opra data in rectal cancer patients presented at asco20
-
1:41
alan p. venook, md, explains how the 80405 study and its impact on treatment guidelines
-
1:01
alan venook, md, balancing economics with the efficacy outcomes seen in 80405
-
1:16
howard hochster md, provides thoughts on potential practice changing results of the keynote177 study
-
2:03
alan venook, md, explains the biological difference between left-sided and right-sided crc tumors
-
1:54
alan venook, md, explains how tumor sidedness affects therapeutic choice
-
0:48
dr. venook discusses the future of colorectal cancer treatment
Clip.africa.com - Privacy-policy